1. Home
  2. PGNY vs WGS Comparison

PGNY vs WGS Comparison

Compare PGNY & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Progyny Inc.

PGNY

Progyny Inc.

N/A

Current Price

$29.54

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

N/A

Current Price

$63.84

Market Cap

2.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
PGNY
WGS
Founded
2008
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.7B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
PGNY
WGS
Price
$29.54
$63.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
8
Target Price
$34.42
★ $93.50
AVG Volume (30 Days)
★ 890.5K
746.0K
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
14.04
★ 62.37
EPS
★ 0.63
N/A
Revenue
★ $1,288,661,000.00
$427,539,000.00
Revenue This Year
$6.64
$12.70
Revenue Next Year
$10.16
$24.31
P/E Ratio
$46.32
★ N/A
Revenue Growth
10.40
★ 39.97
52 Week Low
$16.10
$32.21
52 Week High
$33.07
$170.87

Technical Indicators

Market Signals
Indicator
PGNY
WGS
Relative Strength Index (RSI) 65.11 44.05
Support Level $24.89 $56.09
Resistance Level $33.07 $73.04
Average True Range (ATR) 0.80 5.71
MACD 0.12 0.84
Stochastic Oscillator 96.36 54.92

Price Performance

Historical Comparison
PGNY
WGS

About PGNY Progyny Inc.

Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: